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Abstract
INTRODUCTION: Patients with Cystic Fibrosis, especially in adolescence, could develop endocrine and metabolic
complications, related to nutritional state and chronic inflammation. They develop a progressive decrease in lean
body mass correlated with the progression of lung disease.Adipose tissue is involved as well and adipocytokines
are a possible link between malnutrition and long term complications. PATIENTS AND METHODS: In 24 Cystic
Fibrosis adolescents we studied auxological, nutritional, glycometabolic, endocrine patterns, together with leptin,
adiponectin and resistin levels. We selected patients not affected by diabetes, insulin resistance, malnutrition,
acute  inflammatory  states  so  as  to  avoid  possible  influences on the  adipocytokines.  RESULTS:  All  patients
presented with an adequate BMI centile, with no statistically significant difference versus controls. HOMA IR and
HOMA B% are in the normal range but lower than in controls, expression of a lower insulin-resistance with a
lower insulin secretion. Leptin is significantly higher than in controls and maintains a correlation with BMI and
gender. Resistin levels are more elevated in Cystic Fibrosis than in controls, with a statistically significant direct
correlation with CRP (C-reactive protein) and insulinemia T0’ and T120’.Adiponectin is significantly higher in
Cystic  Fibrosis,  inversely  correlated  with  CRP  and  insulinemia  and  directly  with  cholesterol  and
HDL-cholesterol.CONCLUSIONS:The detection of adipocytokines levels could improve the metabolic follow-up of
these patients: the maintenance of an adequate leptin gender difference is useful in the follow-up of puberty in
adolescence. Adiponectin could be a marker of insulin sensitivity and prevent protein catabolism and loss of lean
body mass. Resistin levels may be used as a marker of insulin resistance and may indicate the severity of chronic
inflammation.This is the first study available in literature about adiponectin levels in pediatric Cystic Fibrosis
patients and about resistin in Cystic Fibrosis.
Introduction
During the last few years a significant improvement in survival and quality of life, due to progress in diagnosis
and follow-up, was observed in patients with Cystic Fibrosis (CF). However, since CF is characterized by weight
loss, chronic negative energy balance and chronic low-grade inflammation, especially in adolescents, several
complications related to endocrine and nutritional profile are described.
Long-term complications of CF include a significant decrease in lean body mass and the lean mass correlates with
the progression of lung disease [1].
Leptin secretion is pulsatile and varies following a circadian rhythm; furthermore it depends on BMI and whole
adipose  tissue.  A  significant  gender-dependent  difference  is  described,  with  higher  levels  in  females  and
significant differences during pubertal development. Caloric intake significantly influences leptin secretion and
malnutrition decreases leptin levels [2; 3; 4]. Furthermore leptin plays an important role in energy balance and
may be affected by hormonal and metabolic derangement associated with chronic disease. Serum concentrations
of leptin are decreased in children with CF and associated with clinical conditions and body composition of the
patients [5].
Adiponectin is principally secreted by visceral and subcutaneous adipocytes. Adiponectin has antiatherogenic and
antiphlogistic properties [6]; moreover it regulates glucose and lipid metabolism, increases insulin sensitivity and
ameliorates  energy  homeostasis.  Adiponectin  levels  increase  in  conditions  of  negative  energy  balance  [6].
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Besides adiponectin levels are reduced in obesity, with a possible role in insulin resistance associated either with
visceral obesity or with inflammatory diseases. Adiponectin is higher in adult CF patients than in healthy controls
[7]; furthermore adiponectin is paradoxically more elevated in CF patients in adequate nutritional conditions and
it is decreased in CF patients with malnutrition [8], but no data are reported in CF children. However, in a recent
study CF patients showed normal levels of adiponectin despite abnormal glucose tolerance or diabetes and/or
subclinical chronic inflammation [9].
In humans, resistin levels are more elevated in females (during childhood and adolescence) than in males of
equivalent  pubertal  stage.  Data about the  correlation between resistin and adiposity,  BMI,  type 2 Diabetes
Mellitus are not clear and homogeneous, even if resistin could be enhanced in chronic inflammatory diseases,
thus amplifying insulin resistance. Patients with CF are possible candidates to these metabolic risks, and resistin
could clarify some links between nutritional and inflammatory state and secondary diseases in CF. Furthermore
no data are available in literature about resistin levels in CF.
We studied young patients with CF in order to evaluate endocrine profile, glycometabolic and insulinemic state,
as  well  as  leptin,  adiponectin  and  resistin  levels.  We compared their  levels  with  those of  healthy controls,
matched for age, sex, BMI and pubertal stage.
Materials And Methods
We studied 24 patients (14 M; 10 F, age 13.3 ± 2.6 years) affected by mild CF disease, selected between all
patients (72: 36 M; 36 F) in peripubertal age followed by the “Regional Center for Cystic Fibrosis” of Palermo.
The selection respected the following criteria:
age: 10-17 years;
diagnosis: CF diagnosis was confirmed by pathological sweat chloride testing and genetic testing in all patients;
clinical state: during the phase of the study no acute disease was documented. We considered as signs of acute
disease: fever, increase of cough and/or sputum, reduced tolerance to exercise, decline of the lung function,
worsening of thorax auscultation, decrease in feeding and/or weight, increase in C-reactive protein (CRP) and
sedimentation rate.
Glucose tolerance tests: patients did not present CFRD (CF related diabetes); all patients were studied with an
OGTT (Oral Glucose Tolerance Test: detection of glycaemia and insulin at standardized times after 1.75 g/kg
maximum 75 g of oral glucose intake) and had a normal OGTT. We evaluated HOMA-IR (Homeostatic Model
Assessment of Insulin-Resistance) and HOMA B% (B-cell function) in our patients. HOMA-IR was computed as
follows: fasting insulin (µIU/ml) × fasting glucose (mmol/ml)/22.5. HOMA-B was calculated using the following
formula: 20 × fasting insulin (µIU/ml)/fasting glucose (mmol/ml).
Treatment: neither systemic nor inhaled corticosteroids were administered to patients since a six-month period
before study and in the course of study;
Furthermore CF patients did not  receive lung and/or bowel transplantation and presented with an adequate
nutritional status. The nutritional status was based on nutritional indexes (proteins, albumin, hemoglobin, ferritin,
cholesterol, triglycerides). All the cited parameters were studied to define as adequate the nutritional condition of
the patients (see table 1).
These patients were compared with 30 (16 M, 14 F) healthy controls matched for age, sex, BMI and pubertal
stage.
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Table 1: Mean ± standard deviation and correlations (p values) of age, Tanner Stage, BMI, HOMA IR, HOMA B%,
leptin, adiponectin and resistin levels in CF patients and in controls.
All blood samples were collected in the morning after a night fast. Adipocytokines were detected using ELISA
tests (Linco Research, St Charles), and the test sensitivity was 0.5 ng/ml, 0.78 ng/ml; 0.16 ng/ml, for leptin,
adiponectin and resistin respectively. TSH was detected by an immunometric assay in chemiluminescence in solid
phase; T3 and T4 were detected by an immunoenzymatic assay in chemiluminescence in solid phase; cortisol,
FSH and LH were detected by an immunoenzymatic assay in chemiluminescence.
The  genetic  study  of  the  patients  was  performed identifying  mutations  in  their  CFTR gene.  The  mutations
described  were  documented  by  performing  direct  sequencing  analysis  of  the  complete  coding  regions  and
flanking intronic sequences of the CFTR gene. In order to detect gene deletions or duplications that could not be
identified by a direct sequencing method the foregoing analysis was followed by multiplex ligation-dependent
probe amplification (MLPA) analysis.
All  variables were tested for  normality with the Anderson-Darling normality test,  and expressed as mean ±
standard deviation (M ± SD). The degree of linear relationship between clinical, microbiological and biochemical
parameters was calculated using Pearson product moment correlation coefficient;  statistical  significance was
accepted at p less than 0.05. Calculations were performed using MiniTAB release 14.1 Statistical Software.
Results
All patients presented with an adequate BMI centile (43.57 ± 32.98) and showed a mild gender difference (M:
35.63 ± 32.44; F: 54.70 ± 32), with no statistically significant difference versus healthy controls (see table 1).
According to international data, in our patients the more frequent genetic mutation was ∆F508: 15 patients
presented  with  ∆F508  mutation:  10  were  homozygous  and  5  were  heterozygous,  associated  with  other
mutations; 4 patients presented with N1303K missense mutation; 3 patients presented with unknown mutations;
2 patients presented with rare mutations. Furthermore 19/24 (79%) of the enrolled patients presented with a
class II mutation (∆F508 or N1303K) with a consequent maturative blockage of CFTR which does not reach cell
wall and is destroyed in endoplasmic reticulum.
Nutritional indexes (proteins, albumin, hemoglobin, ferritin, cholesterol, triglycerides) were studied to define as
adequate the nutritional condition of the patients (see table 2).
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Table 2: Mean ± standard deviation and correlations (p values) of nutritional indexes between CF patients and
control group.
A statistically significant correlation between HDL and cholesterol was observed (r = 0.74; p = 0.002).
CRP was in the normal range in 21/24 patients, mildly positive in three, with a median value of 0.35 (n.v.<0.5).
The sedimentation rate was in the normal range in all patients.
Thyroid function was studied by the detection of serum levels of TSH, fT4, T3, T4. TSH levels were 2.41 ± 1.46
uU/ml, with a different gender-dependent pattern of TSH levels: 1.92 ± 0.87 with a median of 1.92 in males,
3.24 ± 1.93 with a median of 3.09 in females. No significant difference of fT4, T4, T3, ACTH and cortisol levels
was evidenced neither between males and females nor between CF patients and controls (see table 3).
Table 3: Mean ± standard deviation and correlations (p values) of ACTH, cortisol, FSH, LH, thyroid hormones
levels in CF patients and in controls.
ACTH and cortisol levels were in the normal range (see table 3) without any significant correlation with clinical
signs and endocrine assays, except for a direct statistically significant correlation between cortisol and resistin (r
= 0.5; p <0.01). HOMA IR and HOMA B% were in the normal range but lower than in controls, expression of a
lower insulin-resistance with a lower insulin secretion (see table 1). HOMA IR was inversely correlated with leptin
and adiponectin; directly correlated with resistin (r = 0.358; p = 0.086). HOMA B% was inversely correlated with
leptin and adiponectin, but directly correlated with resistin. No statistically significant correlation was observed
between Tanner stage and insulin, glucose levels, HOMA-IR and HOMA B% either in males or females. Leptin
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levels  were  significantly  higher  in  CF  (8.71  ±  10.04  ng/ml;  median:  5.48)  than  in  controls;  however  the
physiological gender difference described in controls was also maintained and more evident in CF patients in
whom leptin was significantly lower in males (5.43 ± 6.26) than in females (11.66 ± 12.09) with leptin levels
significantly more elevated in CF females than in control females (6.16 ± 6.73) (see figure 1).
Figure 1: Leptin, adiponectin and resistin levels (median) in CF patients and healthy controls.
Leptin levels had a statistically significant correlation with BMI (r = 0.77, p = 0.009) and ACTH (r = -0.75; p =
0.021) and showed a direct correlation with insulinemia (T0’  and T120’) even if  not  reaching the statistical
significance.  No significant  correlation was observed between leptin and CRP,  total  blood proteins,  albumin,
hemoglobin, ferritin, Tanner stage in males and in females. Adiponectin levels in CF were 11 ± 3.92 µg/ml
(median:  11.18  µg/ml)  higher  than  in  controls:  8.63  ±  1.67  µg/ml  (median:  8.38  µg/ml).  In  CF  males
adiponectin levels were 11.81 ± 3.99 (median: 12.20), higher than in controls: 7.8 ± 1.52 (median: 7.78);. CF
females had lower adiponectin levels 9.86 ± 3.73 (median: 10.23) than CF males and than females controls:
9.88  ±  1.04  (median:  9.83)  (see  figure  1).  No  statistically  significant  correlation  was  evidenced  between
adiponectin and Tanner stage in males and females.
Adiponectin levels were inversely correlated with CRP, insulinemia (T0’ and T120’) and presented a statistically
significant direct correlation with serum cholesterol (r = 0.51; p = 0.01) and HDL- cholesterol (r = 0.725; p =
0.002). Resistin levels in CF were 2.05 ± 0.89 ng/ml (median: 1.68 ng/ml) significantly higher than in controls:
0.93 ± 0.42 ng/ml (median: 0.83 ng/ml). In CF males resistin levels were 2.07 ± 0.89 ng/ml (median: 1.68
ng/ml) higher than in controls: 0.93 ± 0.29 ng/ml (median: 0.98 ng/ml); in CF females resistin levels were 2.03
± 0.93 ng/ml (median: 1.72 ng/ml), higher than in control females: 0.92 ± 0.62 ng/ml (median: 0.73 ng/ml)
(see figure 1). Resistin levels showed a statistically significant correlation with: cortisol (r = 0.5; p < 0.01); CRP
(r = 0.81; p <0.001 in the whole group; r = 0.71; p = 0.004 in the males group; r = 0.95; p <0.001 in the
females group); serum proteins (r = 0.57; p <0.005); lipids (r = 0.972; p = 0.028); insulinemia T0’ (r = 0.597;
p = 0.019) and insulinemia T120’ (r  = 0.674; p = 0.012). No significant correlation was detected between
resistin and Tanner stage either in males or in females.
Discussion
We selected 24 patients (14 M; 10 F, age 13.3 ± 2.6 years) in peripubertal age, affected by mild CF disease
without any documented acute disease during the study follow up. During the study all patients showed a normal
OGTT, an adequate nutritional status and received neither steroids nor organ transplantation. We selected our
patients in order to evaluate an unbiased sample of CF adolescents, without possible influences of diabetes
and/or insulin resistance, malnutrition or acute inflammatory states on the adipocytokines pattern. We evaluated
plasma levels of: thyroid hormones, ACTH, cortisol, FSH, LH, leptin, adiponectin and resistin and we correlated
them with auxological data, nutritional indexes, glycometabolic pattern and insulin resistance. All patients had
HOMA IR and HOMA B% in the normal range, with values lower than in controls, expression of a lower insulin
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resistance with a reduced insulin secretion, possible expression of the initial endocrine pancreatic involvement.
However no patients had hyperglycemic values, according to inclusion criteria.
Leptin
Leptin levels are described to be related to age, gender, caloric intake, diet composition, BMI. Leptin is reduced in
subjects who follows a hypocaloric diet, independently from weight loss [2; 4; 8]. Our CF patients followed a
hypercaloric diet although the malabsorption decreased the efficacy of the nutritional treatment on BMI and leptin
levels. Leptin levels were significantly more elevated in our CF patients than in controls, linked to cytokines
secretion [11]. This difference was higher in females who showed more elevated BMI. However the physiological
gender  difference  in  leptin  levels  was  maintained  in  our  patients.  Furthermore  we  observed  a  statistically
significant correlation with FSH and HDL-cholesterol. The maintenance of a statistically significant correlation with
FSH levels emphasizes the role of leptin on puberty and on the physiological regulation of hypophyseal secretion
in patients with a good clinical outcome. Higher leptin levels in CF could be secondary to immunological hits and
IL6  and  TNF  alpha  secretion.  Moreover  leukocyte  cytokines  could  contribute  to  the  poor  growth  and  the
hypercatabolic state typical of these patients [11].
Adiponectin
Adiponectin is considered as a marker of insulin sensitivity, with decreased levels in obesity, inflammatory states
and in insulin-resistant patients [9; 12]. Other studies demonstrated higher adiponectin levels in well nourished
adult CF patients than in healthy controls [7; 8; 9] and normal adiponectin levels in CF with diabetes or impaired
glucose  tolerance  and/or  positive  inflammatory  markers  [9].  Adiponectin  levels  were  mildly  higher  in  our
adolescents than in controls, linked to the low malnutrition state typically present in CF. This difference was
described in CF males but not in CF females, linked to the higher BMI. In our patients we found a significant
correlation between insulin-resistance indexes and adipocytokines: adiponectin was inversely  correlated with
insulin,  HOMA IR  and  HOMA B%,  as  previously  described  in  obese  children  [7].  Higher  adiponectin  levels
preserved our adolescents, patients at risk of severe malnutrition [8], from insulin resistance and lean body mass
decrease. Moreover these are the first data available about adiponectin levels in pediatric CF patients.
Resistin
The data reported in literature about resistin levels are controversial, both in correlation with BMI and with the
progression of puberty; however inflammatory cytochines increase resistin levels [13]. In our patients resistin
levels were more elevated than in controls and showed a significant direct correlation with CRP. Nevertheless
resistin increase may be the effect of chronic inflammatory pattern typical of CF [9]. Similarly in patients with
chronic kidney disease [14] and in critically ill patients serum resistin is correlated to inflammatory markers as
CRP [15]. A statistically significant direct correlation with cortisol was also observed in our patients: this datum is
original and possible linked to the positive correlation with CRP. In fact cortisol is a marker of chronic stress and
has a statistically significant direct correlation with CRP (r = 0.505; p = 0.033). Furthermore resistin is directly
correlated with HOMA IR and has a statistically significant correlation with insulinemia (T0’ and T120’).
Despite  the  reputation  of  CF  as  a  progressive,  lethal  disease,  proper  management  of  the  full  spectrum of
CF-related endocrine disorders offers major opportunities to reduce morbidity and improve quality of life. The
detection of adipocytokines levels could improve the metabolic follow-up of these patients: the maintenance of
adequate leptin gender difference is useful in the follow-up of puberty in adolescence. Adiponectin could be a
marker of insulin sensitivity. Furthermore it could prevent protein catabolism and lean body mass drop. Resistin
correlates with insulin resistance and with the severity of chronic inflammation. Our findings emphasize the need
for a comprehensive endocrine and metabolic evaluation and a long-term follow-up in patients with CF.
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